This inventor holds 1 USPTO granted patent. Top assignee: Novartis Ag. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Dominik Feuerbach: Innovator in Antibody Stabilization
Introduction
Dominik Feuerbach is a notable inventor recognized for his contributions to the field of biotechnology. He is currently associated with Novartis AG, a leading global healthcare company. His work primarily focuses on the development of innovative solutions in the realm of antibodies.
Latest Patents
Dominik Feuerbach holds a patent for TREM2 Stabilizing Antibodies. This patent represents a significant advancement in the stabilization of antibodies, which can have profound implications for therapeutic applications.
Career Highlights
Throughout his career, Dominik has demonstrated a commitment to scientific excellence and innovation. His work at Novartis AG has positioned him as a key player in the biotechnology sector, contributing to the development of cutting-edge medical solutions.
Collaborations
Dominik collaborates with Fabrizio Gasparini, leveraging their combined expertise to drive forward innovative projects within their organization.
Conclusion
Dominik Feuerbach's contributions to the field of biotechnology, particularly through his patent on TREM2 Stabilizing Antibodies, highlight his role as an influential inventor. His ongoing work at Novartis AG continues to pave the way for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile